The Antiretroviral Therapy (ART) coverage for adult women living with HIV in the Netherlands has shown a consistent annual increase from 2013 to 2023. In 2023, the coverage stood at 86. The percentage increase year-on-year indicates a gradual deceleration, with the highest growth observed in 2013 at 1.33% and a decrease to 1.18% in 2023. The Compound Annual Growth Rate (CAGR) over the last five years leading up to 2023 is 1.21%. Forecasted data suggests a slower growth trend, with an anticipated CAGR of 0.9% from 2024 to 2028, amounting to a projected 4.6% growth overall during the forecast period.
Future trends to watch for:
- Monitoring the impact of policy changes or new health initiatives on the ART coverage rate.
- Analyzing the impact of technological advancements and improved healthcare access on the therapy coverage.
- Observing demographic shifts and their potential effects on the rate of HIV diagnosis and treatment uptake.
